Pammit, Michael A <br/><br/>
Intranasal interleukin-12 treatment promotes antimicrobial clearance and survival in pulmonary Francisella tularensis subsp. novicida infection.  [electronic resource] 

 -  Antimicrobial agents and chemotherapy  Dec 2004 
 - 4513-9 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0066-4804 
<br/><br/><label>Standard No.: </label>10.1128/AAC.48.12.4513-4519.2004  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adjuvants, Immunologic--administration & dosage<br/>Administration, Intranasal<br/>Animals<br/>Anti-Bacterial Agents--therapeutic use<br/>Female<br/>Francisella tularensis<br/>Gentamicins--therapeutic use<br/>Interferon-gamma--therapeutic use<br/>Interleukin-12--administration & dosage<br/>Lung--microbiology<br/>Mice<br/>Mice, Inbred BALB C<br/>Phagocytosis--drug effects<br/>Survival Analysis<br/>Tularemia--drug therapy